Emergence of delafloxacin-resistant staphylococcus aureus in brooklyn, New York

Alejandro Iregui; Zeb Khan; Saquib Malik; David Landman; John Quale

doi:10.1093/cid/ciz787

Emergence of delafloxacin-resistant staphylococcus aureus in brooklyn, New York

Alejandro Iregui
, Zeb Khan
, Saquib Malik
, David Landman
, John Quale

Medicine

SUNY Downstate Health Sciences University

SUNY Downstate Health Sciences University

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Abstract

Delafloxacin is an option for infections due to methicillin-resistant Staphylococcus aureus. In 2017, 22% of isolates from 7 hospitals in Brooklyn, New York, were nonsusceptible to delafloxacin. Isolates belonging to ST105, a strain associated with healthcare-related infections, predominated. Resistance was also found in ST8, a strain (USA300) associated with community-associated infections.

Original language	English
Pages (from-to)	1758-1760
Number of pages	3
Journal	Clinical Infectious Diseases
Volume	70
Issue number	8
DOIs	https://doi.org/10.1093/cid/ciz787
State	Published - Apr 15 2020

Keywords

Antibiotic resistance
Delafloxacin
Staphylococcus aureus

Access to Document

10.1093/cid/ciz787

Cite this

@article{3b9bb50908924d918397fb2c214da618,

title = "Emergence of delafloxacin-resistant staphylococcus aureus in brooklyn, New York",

abstract = "Delafloxacin is an option for infections due to methicillin-resistant Staphylococcus aureus. In 2017, 22\% of isolates from 7 hospitals in Brooklyn, New York, were nonsusceptible to delafloxacin. Isolates belonging to ST105, a strain associated with healthcare-related infections, predominated. Resistance was also found in ST8, a strain (USA300) associated with community-associated infections.",

keywords = "Antibiotic resistance, Delafloxacin, Staphylococcus aureus",

author = "Alejandro Iregui and Zeb Khan and Saquib Malik and David Landman and John Quale",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].",

year = "2020",

month = apr,

day = "15",

doi = "10.1093/cid/ciz787",

language = "English",

volume = "70",

pages = "1758--1760",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

number = "8",

}

TY - JOUR

T1 - Emergence of delafloxacin-resistant staphylococcus aureus in brooklyn, New York

AU - Iregui, Alejandro

AU - Khan, Zeb

AU - Malik, Saquib

AU - Landman, David

AU - Quale, John

PY - 2020/4/15

Y1 - 2020/4/15

N2 - Delafloxacin is an option for infections due to methicillin-resistant Staphylococcus aureus. In 2017, 22% of isolates from 7 hospitals in Brooklyn, New York, were nonsusceptible to delafloxacin. Isolates belonging to ST105, a strain associated with healthcare-related infections, predominated. Resistance was also found in ST8, a strain (USA300) associated with community-associated infections.

AB - Delafloxacin is an option for infections due to methicillin-resistant Staphylococcus aureus. In 2017, 22% of isolates from 7 hospitals in Brooklyn, New York, were nonsusceptible to delafloxacin. Isolates belonging to ST105, a strain associated with healthcare-related infections, predominated. Resistance was also found in ST8, a strain (USA300) associated with community-associated infections.

KW - Antibiotic resistance

KW - Delafloxacin

KW - Staphylococcus aureus

UR - https://www.scopus.com/pages/publications/85083095032

U2 - 10.1093/cid/ciz787

DO - 10.1093/cid/ciz787

M3 - Article

C2 - 31412357

SN - 1058-4838

VL - 70

SP - 1758

EP - 1760

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 8

ER -

Emergence of delafloxacin-resistant staphylococcus aureus in brooklyn, New York

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this